JUVE Nachricht vom 19.03.2019 - Generics manufacturers prevail over Hogan Lovells client MSD

Various generics manufacturers have won in the second instance in the dispute over supplementary protection certificates for cholesterol-lowering drug Inegy. The Higher Regional Court Düsseldorf dismissed the appeal of US originator Merck Sharp Dome (MSD) (case IDs: I-2 U 58/18 - I-2 U 64/18 and I-2 U 82/18). The various pharmaceutical companies may continue to market imitation products in Germany, using the active substance combination ezitimibe and simvastatin.

Read the whole article Generics manufacturers prevail over Hogan Lovells client MSD.